IDL-2965 Oral Capsule

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
85	特発性間質性肺炎	1

85. 特発性間質性肺炎

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03949530 (ClinicalTrials.gov)	April 16, 2019	6/5/2019	A Study of Safety & Blood Levels of IDL-2965in Healthy Subjects and Patients With a Special Type of ...	IDL-2965- A Phase I, Randomized, Double-blind, Placebo-controlled, Single and Multiple OralDose, Saf ...	Healthy Volunteers;Idiopathic Pulmonary Fibrosis	Drug: IDL-2965 Oral Capsule;Drug: Placebos	Indalo Therapeutics, Inc.	NULL	Terminated	18 Years	60 Years	All	6	Phase 1	United Kingdom

First Previous1Next Last